Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PRCP | P42785 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CTRC | Q99895 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6253800 | 0.90 | MEN1 (0.32) | CYP2C9CYP2C19 | |
| SCHEMBL5855954 | 0.79 | SLC6A2 (0.40) | KDM4EHSD17B10ALDH1A1 | |
| SCHEMBL249120 | 0.77 | CYP2C9 (0.42) | CA2CYP2C9CYP2C19KDM4EADORA3 | |
| SCHEMBL12525029 | 0.77 | CYP2C9 (0.42) | CA2CYP2C9CYP2C19KDM4EADORA3 | |
| SCHEMBL3706077 | 0.77 | CYP2C9 (0.42) | CA2CYP2C9CYP2C19KDM4EADORA3 | |
| SCHEMBL7306016 | 0.77 | CYP2C9 (0.42) | CA2CYP2C9CYP2C19KDM4EADORA3 | |
| SCHEMBL12524998 | 0.77 | CYP2C9 (0.42) | CA2CYP2C9CYP2C19KDM4EADORA3 | |
| SCHEMBL9360043 | 0.77 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL23841973 | 0.76 | CYP2C9 (0.41) | CA2CYP2C9CYP2C19KDM4EADORA3 | |
| SCHEMBL10448418 | 0.76 | HTR2C (0.47) | CYP2C19GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120252-B | Preparation method of ramipril key intermediate derivative | 浙江工业大学 | 2024-10-29 | — | — | CN | claimed |
| CN-116120252-A | Preparation method of ramipril key intermediate derivative | 浙江工业大学 | 2023-05-16 | — | — | CN | claimed |
| WO-2002004020-A2 | PATHOGEN RESISTANCE IN ORGANISMS | MPB COLOGNE GMBH (DE) | 2002-01-17 | — | — | WO | claimed |
| US-5911987-A | NEWCASTLE DISEASE VIRUS | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 1999-06-15 | — | — | US | claimed |
| EP-0749487-A1 | CELL SURFACE PROTEIN AND EFFECTOR CELL BONDING REAGENT | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 1996-12-27 | — | — | EP | claimed |
| WO-1995024490-A1 | CELL SURFACE PROTEIN AND EFFECTOR CELL BONDING REAGENT | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 1995-09-14 | — | — | WO | claimed |
| EP-0367233-A2 | Process for the preparation of 2-(2-thienyl)-ethylamine and derivatives thereof | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-05-09 | — | — | EP | claimed |
| US-4874876-A | ACYLATING THIOPHENE, REDUCING, HYDROLYZING | OCCIDENTAL CHEMICAL CORPORATION (US) | 1989-10-17 | — | — | US | claimed |
| JP-2196784-A | — | — | None | — | — | JP | disclosed |
| JP-8067657-A | — | — | None | — | — | JP | disclosed |
| EP-4585264-A2 | HUMAN CGRP RECEPTOR BINDING PROTEINS | AMGEN INC. (US) | 2025-07-16 | — | — | EP | disclosed |
| CN-113908268-B | Use of antibodies in the preparation of a medicament for the treatment or prevention of migraine | 美国安进公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20250163160-A1 | Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes Thereof | AMGEN INC. | 2025-05-22 | — | — | US | disclosed |
| US-12297260-B2 | DKK1 antibodies and methods of use | AMGEN INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-4874876-A | ACYLATING THIOPHENE, REDUCING, HYDROLYZING | OCCIDENTAL CHEMICAL CORPORATION (US) | 1989-10-17 | — | — | US | disclosed |
| US-4469768-A | Electrophotographic light-sensitive material comprising a charge-generating material and a charge-transporting material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-04 | — | — | US | disclosed |
| US-4443461-A | N-[2-[[1-[1H-Indolylalkyl- or oxoalkyl]-4-piperidinyl]-amino]-2-oxoethyl]-arylcarboxamide derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1984-04-17 | — | — | US | disclosed |
| US-4373100-A | ANIMAL FEEDS | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1983-02-08 | — | — | US | disclosed |
| US-3987185-A | INGIBITS ANTIGEN-ANTIBODY REACTIONS IN ANIMALS | RICHARDSON-MERRELL INC. (US) | 1976-10-19 | — | — | US | disclosed |
| JP-H00867657-A | — | — | 0001-01-01 | — | — | JP | disclosed |